Key Insights

Highlights

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
Showing all 1 trials

Research Network

Active Sponsors

  • Office of Rare Diseases (ORD)1
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
  • Rare Diseases Clinical Research Network1
  • University of Pennsylvania1

Top Investigators

Related Conditions

  • Takayasus Arteritis1
  • Microscopic Polyangiitis1
  • Giant Cell Arteritis1
  • Granulomatosis With Polyangiitis Wegeners1
  • Polyarteritis Nodosa1

Activity Timeline